The U.S. Food and Drug Administration said on Thursday it plans to replace animal testing in the development of monoclonal antibody therapies and other drugs with "human-relevant methods," including the use of AI-based models.
The FDA's animal testing requirement will be "reduced, refined, or potentially replaced" with so-called New Approach Methodologies, or NAMs data, which include the use of AI-based models to predict a drug's behavior as well as side effects and testing on human organ-like structures made in a laboratory.
"replacing" sounds worrying
Maybe using AI to only test higher probability of success drugs on animals would be the more reassuring thing for me
There is a lot that AI can do in this space right now that isn’t critical to the possible usage for humans to take. It’s a solid step and could help speed up drug development instead of the US lagging the EU and the rest of the world time and time again.